Research / FCUV / Fundamental state Inspectable configuration
State dimensions Filing 0001683168-20-000987 General Corporate
Capex intensity 50th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.76% · OPTIONAL · VALID
Operating cash generation 75th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-116.26% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
373.95% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 0th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
4.31% · OPTIONAL · VALID
Gross margin 9th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.gross_margin
8.10% · CORE · VALID
Operating margin 36th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.operating_margin
-228.05% · CORE · VALID
R&D intensity 9th Own-history percentile · N=11
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
17.48% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
5.15% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 5/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 1.05%
Current 0.76%
Delta -0.29% Cash Generation Increased
Previous -195.24%
Current -116.26%
Delta 78.98% Growth Increased
Previous 138.80%
Current 373.95%
Delta 235.15% Inventory Pressure Decreased
Previous 24.89%
Current 4.31%
Delta -20.58% Margin Increased
Previous -4.88%
Current 8.10%
Delta 12.97% Profitability Increased
Previous -522.51%
Current -228.05%
Delta 294.46% R And D Intensity Decreased
Previous 19.95%
Current 17.48%
Delta -2.48% Sbc Intensity Increased
Previous 3.60%
Current 5.15%
Delta 1.55% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.